CN110790745A - A kind of preparation method of extracting vitacoxib from waste tablets - Google Patents
A kind of preparation method of extracting vitacoxib from waste tablets Download PDFInfo
- Publication number
- CN110790745A CN110790745A CN201911098041.8A CN201911098041A CN110790745A CN 110790745 A CN110790745 A CN 110790745A CN 201911098041 A CN201911098041 A CN 201911098041A CN 110790745 A CN110790745 A CN 110790745A
- Authority
- CN
- China
- Prior art keywords
- vitacoxib
- extraction
- waste
- extracting
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及药用化学品的制备方法,具体地说,是一种从废片中提取维他昔布的制备方法。The invention relates to a preparation method of medicinal chemicals, in particular to a preparation method of extracting vitacoxib from waste tablets.
背景技术Background technique
维他昔布是一种新型非甾体抗炎药,非甾体抗炎药能够抑制COX-2,从而减少各类前列腺素和血栓素等炎症介质的合成,从而起到解热、镇痛、抗炎的作用。维他昔布适用于宠物缓解骨关节炎引起的疼痛和炎症,可用于骨或软组织围手术期治疗管理。维他昔布咀嚼片在前期的研究和生产过程中由于受到各种因素的影响,导致出现不合格的片剂或有效期过期的片剂,也叫废片,由于维他昔布原料药物合成工艺复杂,导致维他昔布价格较高。出现的这些废片如果能从中可以提取出合格的维他昔布,不仅能合理利用提取的维他昔布,降低生产成本,还可以减轻三废处理的负担,有利于对环境的保护。维他昔布咀嚼片除含有主药维他昔布外,其它含有的辅料有乳糖、微晶纤维素、聚乙烯吡咯烷酮K30、十二烷基硫酸钠、羧甲基淀粉钠和硬脂酸镁。维他昔布咀嚼片的成分复杂,维他昔布的含量低,每片中含量仅为6%,如何寻找一种有效的提取工艺是本发明要解决的问题。Vitacoxib is a new type of non-steroidal anti-inflammatory drug. Non-steroidal anti-inflammatory drugs can inhibit COX-2, thereby reducing the synthesis of various inflammatory mediators such as prostaglandins and thromboxane, thereby antipyretic and analgesic. , anti-inflammatory effect. Vitacoxib is suitable for pets to relieve pain and inflammation caused by osteoarthritis, and can be used for perioperative management of bone or soft tissue. Due to the influence of various factors in the early research and production process of Vitacoxib chewable tablets, unqualified tablets or tablets with expired validity period, also known as waste tablets, appear due to the synthesis process of Vitacoxib raw materials Complex, resulting in a higher price of Vitacoxib. If qualified vitaoxib can be extracted from these waste tablets, not only can the extracted vitaoxib be used reasonably, the production cost can be reduced, but also the burden of the three wastes treatment can be reduced, which is beneficial to the protection of the environment. In addition to the main drug Vitacoxib, the other excipients contained in Vitacoxib Chewable Tablets are lactose, microcrystalline cellulose, polyvinylpyrrolidone K30, sodium lauryl sulfate, sodium carboxymethyl starch and magnesium stearate . The composition of the vitacoxib chewable tablet is complex, the content of vitacoxib is low, and the content of each tablet is only 6%. How to find an effective extraction process is the problem to be solved by the present invention.
在本发明的过程中,为了找到能有效提取维他昔布的制备方法,首先我们对组成维他昔布咀嚼片片剂的成分性质进行了研究。经过对片剂处方中的辅料进行分析和反复的预实验,最后确定了提取的溶剂和提取方法。使用的提取溶剂经回收可以反复套用,有效降低了提取成本。In the process of the present invention, in order to find a preparation method that can effectively extract vitacoxib, we firstly study the properties of the ingredients that make up the vitacoxib chewable tablet. After the analysis of the excipients in the tablet formulation and repeated preliminary experiments, the extraction solvent and extraction method were finally determined. The used extraction solvent can be reused repeatedly after recovery, which effectively reduces the extraction cost.
发明内容SUMMARY OF THE INVENTION
本发明的目是提供一种从废片中提取维他昔布的制备方法,该制备方法操作简单,容易控制,提取收率高,成本低,为从废片中提取维他昔布原料药物提供了一种新的方法。The purpose of the present invention is to provide a preparation method for extracting vitacoxib from waste tablets. provides a new approach.
为达到上述目的,本发明采用以下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
先在干燥的反应瓶中,投入经过粉碎过60目筛的维他昔布废片粉末,然后加入提取溶剂,控制提取温度和提取时间,提取反应完毕,进行过滤,将滤液加热蒸发掉提取溶剂,然后在残余物中加入结晶溶剂,搅拌后过滤,滤饼用纯化水洗涤,烘箱干燥后进行粉碎过60目筛,得到提取的维他昔布原料药物纯品,提取收率在80%以上,含量达到98.5%以上。First, put the vitacoxib waste tablet powder that has been pulverized through a 60-mesh sieve into a dry reaction bottle, then add an extraction solvent, control the extraction temperature and extraction time, and filter the filtrate after heating to evaporate the extraction solvent. , then add a crystallization solvent to the residue, filter after stirring, wash the filter cake with purified water, dry in an oven and pulverize it through a 60-mesh sieve to obtain the pure vitacoxib raw material drug, with an extraction yield of more than 80% , the content reaches more than 98.5%.
所述的提取溶剂为二氯甲烷、乙酸乙酯、三氯甲烷、甲酸乙酯其中的一种或任意组合的混合溶剂,优选的提取溶剂为乙酸乙酯。The extraction solvent is a mixed solvent of one or any combination of dichloromethane, ethyl acetate, chloroform and ethyl formate, and the preferred extraction solvent is ethyl acetate.
所述的提取温度为20-25℃。The extraction temperature is 20-25°C.
所述的提取时间为30-60分钟。The extraction time is 30-60 minutes.
所述的结晶溶剂为纯化水。The crystallization solvent is purified water.
本发明所述的从废片中提取维他昔布的制备方法,更具体地,包含以下步骤:The preparation method of extracting vitacoxib from waste tablets of the present invention, more specifically, comprises the following steps:
首先在干燥的反应瓶中,投入经过粉碎过60目筛的维他昔布废片粉末,然后加入乙酸乙酯,控制提取温度为20-25℃,提取时间为30-60分钟,提取反应完毕,进行过滤,将滤液加热蒸发掉乙酸乙酯,然后在残余物中加入纯化水,搅拌后过滤,滤饼用纯化水洗涤,烘箱干燥后进行粉碎过60目筛,得到提取的维他昔布原料药物纯品,提取收率在80%以上,含量达到98.5%以上。First, put the vitacoxib waste tablet powder that has been crushed through a 60-mesh sieve into a dry reaction bottle, then add ethyl acetate, control the extraction temperature to be 20-25°C, and the extraction time to be 30-60 minutes, and the extraction reaction is completed. , filter, heat the filtrate to evaporate the ethyl acetate, then add purified water to the residue, filter after stirring, wash the filter cake with purified water, dry in an oven, pulverize and pass through a 60-mesh sieve to obtain the extracted vitacoxib The pure product of the raw material drug, the extraction yield is above 80%, and the content is above 98.5%.
本方法操作简单易控,收率高,成本低,为从维他昔布废片中提取维他昔布原料药物提供了一种新的方法。The method is simple and easy to control, has high yield and low cost, and provides a new method for extracting the raw material medicine of vitacoxib from waste vitacoxib tablets.
具体实施方式Detailed ways
下面是本发明的实施例,所述的实施例只是用来说明本发明,而不应当被视为是对本发明的限制。The following are the embodiments of the present invention, which are only used to illustrate the present invention, and should not be regarded as a limitation of the present invention.
实施例1Example 1
先在干燥的反应瓶中,投入经过粉碎过60目筛的维他昔布废片粉末10g,然后加入二氯甲烷30ml,开启搅拌,控制提取温度在20℃,搅拌提取30分钟,提取反应完毕,用布什漏斗进行过滤,将滤液加热蒸发掉二氯甲烷,然后在残余物中加入纯化水10ml,搅拌后过滤,滤饼用纯化水洗涤,烘箱干燥后进行粉碎过60目筛,得到提取的维他昔布原料药物纯品0.53g,提取收率为88.3%,含量为98.7%。First, put 10 g of vitacoxib waste tablet powder that has been crushed through a 60-mesh sieve into a dry reaction bottle, then add 30 ml of dichloromethane, start stirring, control the extraction temperature at 20 °C, and stir and extract for 30 minutes, and the extraction reaction is completed. , filter with a Bush funnel, heat the filtrate to evaporate the dichloromethane, then add 10 ml of purified water to the residue, filter after stirring, wash the filter cake with purified water, pulverize the filtrate and pass through a 60-mesh sieve after drying in an oven to obtain the extracted The pure product of the raw material drug of Vitacoxib is 0.53g, the extraction yield is 88.3%, and the content is 98.7%.
实施例2Example 2
先在干燥的反应瓶中,投入经过粉碎过60目筛的维他昔布废片粉末20g,然后加入乙酸乙酯50ml,开启搅拌,控制提取温度在30℃,搅拌提取45分钟,提取反应完毕,用布什漏斗进行过滤,将滤液加热蒸发掉乙酸乙酯,然后在残余物中加入纯化水20ml,搅拌后过滤,滤饼用纯化水洗涤,烘箱干燥后进行粉碎过60目筛,得到提取的维他昔布原料药物纯品1.02g,提取收率为85.0%,含量为99.1%。First, put 20 g of vitacoxib waste tablet powder that has been crushed through a 60-mesh sieve into a dry reaction bottle, then add 50 ml of ethyl acetate, start stirring, control the extraction temperature at 30 ° C, and stir and extract for 45 minutes, and the extraction reaction is completed. , filter with Bush funnel, heat the filtrate to evaporate ethyl acetate, then add 20 ml of purified water to the residue, filter after stirring, wash the filter cake with purified water, dry in an oven, pulverize and pass through a 60-mesh sieve to obtain the extracted 1.02g of pure vitacoxib raw material drug, the extraction yield is 85.0%, and the content is 99.1%.
以上对本发明所提供的从废片中提取维他昔布的制备方法进行了详细介绍,本文中应用了具体案例对本发明的原理及实施方式进行了阐述,以上实施例的说明只是用于帮助理解本发明的方法及其核心思想;同时,对于本领域的一般技术人员,依据本发明的思想,在具体实施方式及应用范围上均会有改变之处,综上所述,本说明书内容不应理解为对本发明的限制。The preparation method for extracting vitacoxib from waste tablets provided by the present invention has been described in detail above. In this paper, specific cases are used to illustrate the principles and implementations of the present invention. The descriptions of the above examples are only used to help understanding The method of the present invention and its core idea; at the same time, for those skilled in the art, according to the idea of the present invention, there will be changes in the specific implementation and application scope. In summary, the content of this specification should not be It is understood as a limitation of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911098041.8A CN110790745A (en) | 2019-11-12 | 2019-11-12 | A kind of preparation method of extracting vitacoxib from waste tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911098041.8A CN110790745A (en) | 2019-11-12 | 2019-11-12 | A kind of preparation method of extracting vitacoxib from waste tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110790745A true CN110790745A (en) | 2020-02-14 |
Family
ID=69444193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911098041.8A Pending CN110790745A (en) | 2019-11-12 | 2019-11-12 | A kind of preparation method of extracting vitacoxib from waste tablets |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110790745A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1578774A (en) * | 2001-10-02 | 2005-02-09 | 法玛西雅公司 | Method for preparing benzenesulfonyl compounds |
WO2005123701A1 (en) * | 2004-06-14 | 2005-12-29 | Pharmacia Corporation | Method for the preparation of diarylisoxazole sulfonamide compounds and intermediates |
CN102464652A (en) * | 2010-11-02 | 2012-05-23 | 北京欧博方医药科技有限公司 | Imidazole derivative, preparation method and application |
CN104910091A (en) * | 2015-03-26 | 2015-09-16 | 北京华睿鼎信科技有限公司 | Preparation method of anhydrous and non-solvation A crystallization parecoxib sodium |
CN105726496A (en) * | 2014-12-12 | 2016-07-06 | 四川科伦药物研究院有限公司 | Parecoxib sodium freeze-dried powder, preparation method and powder product thereof |
-
2019
- 2019-11-12 CN CN201911098041.8A patent/CN110790745A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1578774A (en) * | 2001-10-02 | 2005-02-09 | 法玛西雅公司 | Method for preparing benzenesulfonyl compounds |
WO2005123701A1 (en) * | 2004-06-14 | 2005-12-29 | Pharmacia Corporation | Method for the preparation of diarylisoxazole sulfonamide compounds and intermediates |
CN102464652A (en) * | 2010-11-02 | 2012-05-23 | 北京欧博方医药科技有限公司 | Imidazole derivative, preparation method and application |
CN105726496A (en) * | 2014-12-12 | 2016-07-06 | 四川科伦药物研究院有限公司 | Parecoxib sodium freeze-dried powder, preparation method and powder product thereof |
CN104910091A (en) * | 2015-03-26 | 2015-09-16 | 北京华睿鼎信科技有限公司 | Preparation method of anhydrous and non-solvation A crystallization parecoxib sodium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016539955A (en) | Drug composition, method for producing the same, and use | |
CN104258193A (en) | Drug composition for treating neurasthenia and preventing senile dementia | |
CN103585311A (en) | Preparation method for Spiraea alpina extract | |
CN102093462B (en) | Preparation method and application of 1alpha, 2alpha-dyhydroxyl oleanolic acid | |
CN103755719B (en) | Physalin B crystal and extract preparation method and Physalin B crystal in the application prepared in anti-inflammation drugs | |
CN102030804B (en) | Method for preparing theasapogenol | |
CN110790745A (en) | A kind of preparation method of extracting vitacoxib from waste tablets | |
CN106632566A (en) | Fructus cannabis phytosterol extraction process | |
CN102659899A (en) | Method for extracting purified oleanolic acid from glossy privet fruits | |
CN110960569A (en) | Phyllanthus emblica extract and preparation method and application thereof | |
JP2017515902A (en) | Drug composition for controlling lipemia and body weight and its application method | |
CN103570798B (en) | Method for producing perilla nankinensis sterol by perilla nankinensis cakes | |
CN101371875B (en) | Method for extracting and preparing total saponin of compound abnormal savda mature agent | |
CN103417747A (en) | Traditional Chinese medicine superfine grinding powder for controlling mumps of trionyx sinensis and preparation method thereof | |
CN104107225B (en) | Chinese crude drug Radix Polygalae anticoagulation effective site and extracting method thereof and application | |
CN103585208A (en) | Preparation method of high-quality andrographolide component | |
CN104173413B (en) | Application of Tripterygium wilfordii leaf total terpenes in the preparation of anti-rheumatoid arthritis drugs | |
CN102731309B (en) | A kind of method extracting separating chlorogenic acid from Herba Dendranthematis indici | |
CN102786418A (en) | Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products | |
CN101269124A (en) | Oral preparation, preparation method and application of psyllium polysaccharide | |
CN104744550A (en) | New production method for extracting and separating corosolic acid and ursolic acid from loquat leaf | |
CN104706896A (en) | Vegetable drug for curing cancers and preparation method and application thereof | |
CN102335143A (en) | New process for preparing (sugar-free) smilax bockii warb granules | |
CN109908120B (en) | A kind of active ingredient, extraction method and application of Pteridophyta | |
CN101669989B (en) | A composition containing kidney tea water extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200214 |
|
WD01 | Invention patent application deemed withdrawn after publication |